Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: Effect of cofactors on differentiating lineages

BackgroundRecently, tissue engineering has merged with stem cell technology with interest to develop new sources of transplantable material for injury or disease treatment. Eminently interesting, are bone and joint injuries/disorders because of the low self-regenerating capacity of the matrix secreting cells, particularly chondrocytes. ES cells have the unlimited capacity to self-renew and maintain their pluripotency in culture. Upon induction of various signals they will then differentiate into distinctive cell types such as neurons, cardiomyocytes and osteoblasts.ResultsWe present here that BMP-2 can drive ES cells to the cartilage, osteoblast or adipogenic fate depending on supplementary co-factors. TGFβ1, insulin and ascorbic acid were identified as signals that together with BMP-2 induce a chondrocytic phenotype that is characterized by increased expression of cartilage marker genes in a timely co-ordinated fashion. Expression of collagen type IIB and aggrecan, indicative of a fully mature state, continuously ascend until reaching a peak at day 32 of culture to approximately 80-fold over control values. Sox9 and scleraxis, cartilage specific transcription factors, are highly expressed at very early stages and show decreased expression over the time course of EB differentiation. Some smaller proteoglycans, such as decorin and biglycan, are expressed at earlier stages. Overall, proteoglycan biosynthesis is up-regulated 7-fold in response to the supplements added. BMP-2 induced chondrocytes undergo hypertrophy and begin to alter their expression profile towards osteoblasts. Supplying mineralization factors such as β-glycerophosphate and vitamin D3 with the culture medium can facilitate this process. Moreover, gene expression studies show that adipocytes can also differentiate from BMP-2 treated ES cells.ConclusionsUltimately, we have found that ES cells can be successfully triggered to differentiate into chondrocyte-like cells, which can further alter their fate to become hypertrophic, and adipocytes. Compared with previous reports using a brief BMP-2 supplementation early in differentiation, prolonged exposure increased chondrogenic output, while supplementation with insulin and ascorbic acid prevented dedifferentiation. These results provide a foundation for the use of ES cells as a potential therapy in joint injury and disease.

[1]  C. Dani,et al.  Compactin enhances osteogenesis in murine embryonic stem cells. , 2001, Biochemical and biophysical research communications.

[2]  K. Sasaki,et al.  Survival and function of mouse embryonic stem cell-derived cardiomyocytes in ectopic transplants. , 2003, Cardiovascular research.

[3]  N. Z. Zur Nieden,et al.  In vitro differentiation of embryonic stem cells into mineralized osteoblasts. , 2003, Differentiation; research in biological diversity.

[4]  J. Ntambi,et al.  Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. , 1989, Genes & development.

[5]  Qin Zhang,et al.  Control of , 2021, Agriculture Automation and Control.

[6]  J. Verhaar,et al.  Specific enzymatic treatment of bovine and human articular cartilage: implications for integrative cartilage repair. , 2002, Arthritis and rheumatism.

[7]  R. Tuan,et al.  Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. , 1999, Differentiation; research in biological diversity.

[8]  M. Ryan,et al.  Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. , 1990, The Journal of biological chemistry.

[9]  S. Kawai,et al.  Chondrogenic differentiation of murine embryonic stem cells: Effects of culture conditions and dexamethasone , 2004, Journal of cellular biochemistry.

[10]  B. Oakes,et al.  Orthopaedic tissue engineering: from laboratory to the clinic , 2004, The Medical journal of Australia.

[11]  K. Guan,et al.  Differentiation plasticity of chondrocytes derived from mouse embryonic stem cells , 2002, Journal of Cell Science.

[12]  Makarand V Risbud,et al.  Tissue engineering: advances in in vitro cartilage generation. , 2002, Trends in biotechnology.

[13]  Kozo Nakamura,et al.  The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. , 2004, Arthritis and rheumatism.

[14]  M. Wiles,et al.  Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development , 1995, Molecular and cellular biology.

[15]  J M Polak,et al.  Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. , 2001, Tissue engineering.

[16]  G. Lyons,et al.  Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. , 1995, Development.

[17]  G. Wallukat,et al.  Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. , 1991, Differentiation; research in biological diversity.

[18]  R. McKay,et al.  Embryonic stem cell-derived glial precursors: a source of myelinating transplants. , 1999, Science.

[19]  V. Rosen,et al.  Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  A. Reddi,et al.  Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B (BMP-2B) and modulation by transforming growth factor beta 1 and beta 2. , 1991, Experimental cell research.

[21]  N. Z. Zur Nieden,et al.  Molecular markers in embryonic stem cells. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  C. Dani,et al.  Differentiation of embryonic stem cells into adipocytes in vitro. , 1997, Journal of cell science.

[23]  Richard R. Behringer,et al.  Sox9 is required for cartilage formation , 1999, Nature Genetics.

[24]  A. Reddi,et al.  Extracellular matrix biochemistry , 1984 .

[25]  M. Segal,et al.  Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro , 1996, Mechanisms of Development.

[26]  K. Kaestner,et al.  Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R W Farndale,et al.  A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. , 1982, Connective tissue research.

[28]  B. Soria,et al.  From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus , 2001, Diabetologia.

[29]  K. Messner,et al.  Maturation-dependent durability of spontaneous cartilage repair in rabbit knee joint. , 1999, Journal of biomedical materials research.

[30]  P. Donovan,et al.  Long-term proliferation of mouse primordial germ cells in culture , 1992, Nature.

[31]  T. Jessell,et al.  Control of cell pattern in the developing nervous system: Polarizing activity of the floor plate and notochord , 1991, Cell.

[32]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[33]  E B Hunziker,et al.  Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. , 2002, Osteoarthritis and cartilage.

[34]  N. Z. Zur Nieden,et al.  Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds. , 2004, Toxicology and applied pharmacology.

[35]  H. Sul,et al.  Understanding adipocyte differentiation. , 1998, Physiological reviews.

[36]  Anita B. Roberts,et al.  Peptide Growth Factors and Their Receptors I , 1990, Springer Study Edition.

[37]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.